Full Sail Capital, LLC Pfizer Inc Transaction History

Full Sail Capital, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $6,853 - $8,922	174 Added 3.5%	5,152 $210,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $7,807 - $10,191	187 Added 3.9%	4,978 $255,000
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $4,653 - $5,517	-100 Reduced 2.04%	4,791 $251,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $17,659 - $21,882	-386 Reduced 7.31%	4,891 $253,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $218,045 - $323,216	5,277 New	5,277 $277,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $331,700 - $375,761	-9,237 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $47,689 - $53,784	1,424 Added 18.23%	9,237 $333,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $2,677 - $3,404	-80 Reduced 1.01%	7,813 $292,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $3,524 - $4,134	-111 Reduced 1.39%	7,893 $287,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $40,692 - $49,365	-1,351 Reduced 14.44%	8,004 $248,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $56,600 - $80,870	-2,094 Reduced 18.29%	9,355 $348,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $20,311 - $23,051	-617 Reduced 5.11%	11,449 $432,000
Q3 2019 Nov 20, 2019	BUY	$32.49 - $42.13 $150,656 - $195,356	4,637 Added 62.42%	12,066 $442,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $27,698 - $31,098	-749 Reduced 9.16%	7,429 $270,000
Q1 2019 May 16, 2019	SELL	$37.5 - $41.2 $27,675 - $30,405	-738 Reduced 8.28%	8,178 $347,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $342,998 - $391,055	8,916 New	8,916 $389,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Full Sail Capital, LLC with notifications on news.